REFERENCES
1. Menko FH, Maher ER, Schmidt LS, et al. Hereditary leiomyomatosis and
renal cell cancer (HLRCC): renal cancer risk, surveillance and
treatment. Fam Cancer 2014;13(4):637-+644.
2. Muller M, Ferlicot S, Guillaud-Bataille M, et al. Reassessing the
clinical spectrum associated with hereditary leiomyomatosis and renal
cell carcinoma syndrome in French FH mutation carriers. Clin Genet
2017;92(6):606-615.
3. Forde C, Lim DHK, Alwan Y, et al. Hereditary leiomyomatosis and renal
cell cancer: clinical, molecular, and screening features in a cohort of
185 affected individuals. Eur Urol Oncol 2019.
4. Nix J, Shuch B, Chen V, et al. 2008 Clinical features and management
of hereditary leiomyomatosis and renal cell cancer (HLRCC). J Urol
2012;187(4S):e810-e810.
5. Taniguchi R, Muramatsu H, Okuno Y, et al. Comprehensive genetic
analysis of donor cell derived leukemia with KMT2A rearrangement.
Pediatr Blood Cancer 2018;65(2).
6. Park I, Shim YS, Go H, Hong BS, Lee JL. Long-term response of
metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome
associated renal cell carcinoma to bevacizumab plus erlotinib after
temsirolimus and axitinib treatment failures. BMC Urol 2019;19(1):51.
7. Pollard PJ, Spencer-Dene B, Shukla D, et al. Targeted inactivation of
FH1 causes proliferative renal cyst development and activation of the
hypoxia pathway. Cancer Cell 2007;11(4):311-319.
8. Terada N, Ichioka K, Matsuta Y, Okubo K, Yoshimura K, Arai Y. The
natural history of simple renal cysts. J Urol 2002;167(1):21-23.
9. Lehtonen HJ, Kiuru M, Ylisaukko-Oja SK, et al. Increased risk of
cancer in patients with fumarate hydratase germline mutation. J Med
Genet 2006;43(6):523-526.
10. Ristau BT, Kamat SN, Tarin TV. Abnormal cystic tumor in a patient
with hereditary leiomyomatosis and renal cell cancer syndrome: evidence
of a precursor lesion? Case Rep Urol 2015;2015:303872.
11. Hol JA, Jongmans MCJ, Littooij AS, et al. Renal cell carcinoma in
young FH mutation carriers: case series and review of the literature.
Fam Cancer 2020;19(1):55-63.